Invention Grant
- Patent Title: Protease stabilized, acylated insulin analogues
- Patent Title (中): 蛋白酶稳定，酰化胰岛素类似物
-
Application No.: US12922117Application Date: 2009-03-13
-
Publication No.: US08691759B2Publication Date: 2014-04-08
- Inventor: Peter Madsen , Thomas Boerglum Kjeldsen , Thomas Hoeg-Jensen , Palle Jakobsen , Tina Moeller Tagmose , Janos Tibor Kodra , Patrick William Garibay
- Applicant: Peter Madsen , Thomas Boerglum Kjeldsen , Thomas Hoeg-Jensen , Palle Jakobsen , Tina Moeller Tagmose , Janos Tibor Kodra , Patrick William Garibay
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Richard W. Bork
- Priority: EP08102708 20080318; EP08170231 20081128
- International Application: PCT/EP2009/053017 WO 20090313
- International Announcement: WO2009/115469 WO 20090924
- Main IPC: A61K38/28
- IPC: A61K38/28 ; A61P3/10
Abstract:
Novel acylated insulin analogues exhibiting resistance towards proteases can, effectively, be administered pulmonary or orally. The insulin analogues contain B25H and A14E or A14H.
Public/Granted literature
- US20110105720A1 PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES Public/Granted day:2011-05-05
Information query
IPC分类:
